You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alirocumab

Showing 26 - 50 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Coronary Artery Disease, Thin-cap fIbroatheroma Trial in Kobe (Alirocumab)

Unknown status
  • Coronary Artery Disease
  • Thin-cap fIbroatheroma
  • Alirocumab
  • Kobe, Hyogo, Japan
    Kobe University Graduate School of Medicine, Department of Cardi
Nov 11, 2018

Hypercholesterolemia Trial in Japan (Alirocumab, Placebo, Atorvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • +4 more
  • Ageo-Shi, Japan
  • +29 more
Jan 3, 2019

Alirocumab for Neoatherosclerosis by Using OCT, in Comparison

Recruiting
  • Coronary Artery Disease Progression
  • Alirocumab
  • Kobe, Hyogo, Japan
    Kobe University Graduate School of Medicine, Department of Cardi
May 28, 2018

Hypercholesterolemia Trial in Worldwide (Alirocumab, Placebo (for Alirocumab), Non-statin LMT)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • +3 more
  • Beverly Hills, California
  • +42 more
Jun 29, 2018

Atherosclerotic Cardiovascular Disease Trial in Worldwide (Alirocumab, Placebo, LMT)

Completed
Has Results
  • Atherosclerotic Cardiovascular Disease
  • Alirocumab
  • +2 more
  • Birmingham, Alabama
  • +1387 more
Mar 15, 2019

Hypercholesterolaemia Trial in Worldwide (Alirocumab, Placebo, Lipid-Modifying Therapy (LMT))

Completed
Has Results
  • Hypercholesterolaemia
  • Alirocumab
  • +3 more
  • Encino, California
  • +109 more
May 1, 2018

Hypercholesterolemia Trial in Worldwide (Alirocumab, Lipid-Modifying Therapy (LMT))

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • Lipid-Modifying Therapy (LMT)
  • Huntsville, Alabama
  • +176 more
Jun 29, 2018

Dyslipidemia Trial in Worldwide (Alirocumab, Statins, Ezetimibe)

Completed
Has Results
  • Dyslipidemia
  • Alirocumab
  • +6 more
  • Little Rock, Arkansas
  • +118 more
Apr 30, 2018

Hypercholesterolemia Trial in New York (alirocumab, Placebo)

Completed
  • Hypercholesterolemia
  • alirocumab
  • Placebo
  • New York, New York
    Investigational Site Number 840001
Apr 28, 2017

Hypercholesterolemia Trial in Korea, Republic of, Taiwan (Placebo (for Alirocumab), Alirocumab, Lipid-Modifying Therapy (LMT))

Completed
Has Results
  • Hypercholesterolemia
  • Placebo (for Alirocumab)
  • +2 more
  • Anyang-Si, Korea, Republic of
  • +26 more
Jun 22, 2017

Hypercholesterolemia Trial in Worldwide (Placebo (for alirocumab), Alirocumab, Statin)

Completed
Has Results
  • Hypercholesterolemia
  • Placebo (for alirocumab)
  • +2 more
  • Chandler, Arizona
  • +82 more
Jan 30, 2017

Hypercholesterolemia Trial in Koganei-Shi, Shinjuku-Ku, Suita-Shi (Alirocumab, Placebo (for alirocumab), Atorvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • +2 more
  • Koganei-Shi, Japan
  • +3 more
Sep 27, 2016

Hypercholesterolemia Trial in Rennes, Rueil Malmaison (Alirocumab, Ezetimibe, Ezetimibe Placebo)

Completed
  • Hypercholesterolemia
  • Alirocumab
  • +3 more
  • Rennes, France
  • +1 more
Sep 27, 2016

Hypercholesterolemia Trial in Japan (Placebo (for alirocumab), Alirocumab, Lipid-Modifying Therapy (LMT))

Completed
Has Results
  • Hypercholesterolemia
  • Placebo (for alirocumab)
  • +2 more
  • Adachi-Ku, Japan
  • +31 more
Sep 27, 2016

Hypercholesterolaemia Trial in Worldwide (Alirocumab, Placebo (for alirocumab), Lipid Modifying Therapy (LMT))

Completed
Has Results
  • Hypercholesterolaemia
  • Alirocumab
  • +2 more
  • Bell Gardens, California
  • +34 more
Sep 27, 2016

Hypercholesterolemia Trial in Worldwide (Alirocumab, Placebo (for alirocumab), Ezetimibe)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • +4 more
  • Birmingham, Alabama
  • +125 more
Jun 23, 2016

Hypercholesterolemia Trial in Worldwide (Alirocumab, Ezetimibe, Placebo (for Alirocumab))

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • +3 more
  • Overland Park, Kansas
  • +7 more
Oct 7, 2015

Heterozygous Familial Hypercholesterolemia Trial in Worldwide (LMT (atorvastatin, simvastatin, or rosuvastatin), alirocumab,

Completed
Has Results
  • Heterozygous Familial Hypercholesterolemia
  • LMT (atorvastatin, simvastatin, or rosuvastatin)
  • +2 more
  • Hradec Kralove, Czech Republic
  • +25 more
Sep 29, 2015

Hypercholesterolemia Trial in Worldwide (Alirocumab, Placebo (for alirocumab), Lipid Modifying Therapy (LMT))

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • +2 more
  • Bell Gardens, California
  • +90 more
Jan 11, 2016

Hypercholesterolemia Trial in United States (Alirocumab, Placebo (for alirocumab), Atorvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • +3 more
  • Mesa, Arizona
  • +19 more
Aug 21, 2015

Hypercholesterolemia Trial in United States (Alirocumab, Placebo (for alirocumab), Atorvastatin)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • +2 more
  • Tempe, Arizona
  • +37 more
Aug 21, 2015

Hypercholesterolemia Trial in United States (Placebo (for alirocumab), Alirocumab, Lipid-Modifying Therapy (LMT))

Completed
Has Results
  • Hypercholesterolemia
  • Placebo (for alirocumab)
  • +2 more
  • Birmingham, Alabama
  • +75 more
Oct 7, 2015

Hypercholesterolemia Trial in Worldwide (Alirocumab, Atorvastatin, Ezetimibe)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • +4 more
  • Mobile, Alabama
  • +96 more
Jul 29, 2015

Hypercholesterolemia Trial in Canada, United States (Alirocumab, Placebo)

Completed
Has Results
  • Hypercholesterolemia
  • Alirocumab
  • Placebo
  • Huntsville, Alabama
  • +21 more
Aug 20, 2015

Hypercholesterolemia Trial in Worldwide (Placebo (for alirocumab), Alirocumab, Lipid-Modifying Therapy (LMT))

Completed
Has Results
  • Hypercholesterolemia
  • Placebo (for alirocumab)
  • +2 more
  • Huntsville, Alabama
  • +319 more
Nov 18, 2015